ArticleFrontiers in oncology2023

Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring

Ting Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.